4.5 Article

Emerging therapeutic roles of small heat shock protein-derived mini-chaperones and their delivery strategies

Journal

BIOCHIMIE
Volume 208, Issue -, Pages 56-65

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2022.12.004

Keywords

Mini-peptide; Chaperone; Nanoparticles; Cell penetration peptides; Extracellular vesicles; Apoptosis

Ask authors/readers for more resources

The small heat shock protein (sHsp) family includes proteins that are induced in response to external stimuli and those that are constitutively expressed. These proteins function as molecular chaperones, protecting cells and maintaining their structure. Short sequences derived from sHsps, known as mini-peptides/mini-chaperones, have shown therapeutic potential in various diseases due to their small size and easy uptake into cells. However, their limited stability and enzymatic degradation in circulation have hindered their therapeutic efficacy. Carrier molecules such as nanoparticles and cell penetration peptides have been used to enhance the effectiveness of sHsp mini-chaperones. This review highlights recent advances in the therapeutic potential of sHsp-derived mini-chaperones and strategies for improving their efficacy.
The small heat shock protein (sHsp) family is a group of proteins in which some are induced in response to external stimuli, such as environmental and pathological stresses, while others are constitutively expressed. They show chaperone-like activity, protect cells from apoptosis, and maintain cytoskeletal architecture. Short sequences or fragments ranging from approximately 19-20 residues in sHsps were shown to display chaperone activity in vitro. These sequences are termed sHsp-derived mini-peptides/mini-chaperones. These peptides offer an advantage in providing protective and therapeutic effects over full-length proteins owing to their small molecular weight and easy uptake into the cells. Research on sHsp mini-chaperone therapy has recently received attention and advanced tremendously. sHsp mini-chaperones have shown a wide range of therapeutic effects, such as anti-aggregation of proteins, antiapoptotic, anti-inflammatory, anti-oxidant, senolytic, and anti-platelet activity. The administration of mini-chaperones into the several disease animal models, including experimental autoimmune encephalomyelitis, cataract, age-related macular degeneration, glaucoma, and thrombosis through various routes reduced symptoms or prevented the progression of the disease. However, it was found that the therapeutic potential of sHsp mini-chaperones is limited by their short turnover and enzymatic degradation in circulation. Nonetheless, carrier molecules approach such as nanoparticles, cell penetration peptides, and extracellular vesicles increased their efficacy by enhancing the uptake, retention time, protection from enzymatic degradation, and site-specific delivery without altering their biological activity. In this context, this review highlights the recent advances in the therapeutic potential of sHsp-derived mini-chaperones, their effect in experimental animal models, and approaches for increasing their efficacy. (c) 2022 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available